How does Apelix work?

Apelix, a high-profile drug, offers new treatment hope for patients with certain types of breast cancer. It mainly targets advanced or metastatic breast cancer that is hormone receptor positive, human epidermal growth factor receptor2 negative, and carries PIK3CA gene mutations. This type of breast cancer often does not respond well to traditional treatments, and patients have relatively limited treatment options. The emergence of Apelvis has opened up new treatment paths for these patients.

The core mechanism of Apelix’s action lies in its ability to precisely inhibit the activity of PI3Kα enzyme. PI3Kα enzyme plays a key role in the growth, proliferation and metastasis of cancer cells. When the PIK3CA gene is mutated, the activity of the PI3Kα enzyme will be abnormally enhanced, thereby promoting the malignant progression of cancer cells. Apelvis specifically binds to the PI3Kα enzyme and reduces its activity, thereby blocking the signal transduction pathways in cancer cells and inhibiting the growth and spread of cancer cells.

It is worth mentioning that Apelvis is highly selective in its inhibitory effect onPI3Kα enzyme. Compared with other isomers such as PI3Kβ, PI3Kγ and PI3Kδ, the inhibitory effect of apelvis on PI3Kα is more significant. This selective inhibition not only enhances the therapeutic effect of the drug, but also reduces unnecessary side effects, allowing patients to receive treatment more safely.

In clinical practice, apelvis is often used in combination with endocrine therapy drugs such as fulvestrant. This combination treatment can more comprehensively inhibit the growth of breast cancer cells, extend patients' progression-free survival, and reduce the need for chemotherapy. For those patients with severe disease who have already developed organ metastasis, the combination treatment with Apelvis has also shown significant therapeutic effects, giving these patients more chances of survival.

Overall, apelvis provides a new, effective treatment option for patients with certain types of breast cancer through its unique mechanism. With the deepening of research and the expansion of clinical application, we have reason to believe that Apelix will play a more important role in the treatment of breast cancer in the future.